Mycobacterium species cause a variety of clinical diseases, some of which may be species specific. Therefore, it is clinically desirable to rapidly identify and differentiate mycobacterial isolates to the species level. We developed a rapid and high-throughput system, MycoID, to identify Mycobacterium species directly from acid-fast bacillus (AFB)-positive mycobacterial culture broth. The MycoID system incorporated broad-range PCR followed by suspension array hybridization to identify 17 clinically relevant mycobacterial complexes, groups, and species in one single reaction. We evaluated a total of 271 AFB-positive culture broth specimens, which were identified by reference standard methods in combination with biochemical and molecular tests. The overall identification agreement between the standard and the MycoID system was 89.7% (perfect match) or 97.8% (one match in codetection). In comparison to the standard, the MycoID system possessed an overall sensitivity of 97.1% and specificity of 98.8%. The 159 Mycobacterium avium-M. intracellulare complex isolates were further identified to the species level by MycoID as being M. avium (n ‫؍‬ 98; 61.1%), M. intracellulare (n ‫؍‬ 57; 35.8%), and mixed M. avium and M. intracellulare (n ‫؍‬ 2; 1.3%). M. avium was recovered more frequently from sterile sites than M. intracellulare (odds ratio, 4.6; P ‫؍‬ 0.0092). The entire MycoID procedure, including specimen processing, can be completed within 5 h, providing rapid and reliable identification and differentiation of mycobacterium species that is amenable to automation. Additional differentiation of Mycobacterium avium-M. intracellulare complex strains into M. avium and M. intracellulare may provide a tool to better understand the role of Mycobacterium avium-M. intracellulare complex isolates in human disease.
The increasing numbers of infections caused by mycobacteria other than tuberculosis have intensified the need for the introduction of rapid methods for isolating and identifying clinically encountered mycobacteria. The detection of pathogenic mycobacterial species continues to depend mainly on mycobacterial culture. The use of liquid culture media with continuous monitoring has significantly improved test sensitivity and test turnaround time. The Bactec mycobacterial growth indicator tube (MGIT) 960 system (Becton Dickinson Microbiology Systems, Sparks, MD), which is a fully automated, continuous-monitoring, nonradiometric, noninvasive device, is sensitive and shortens the turnaround time by 2 to 27 days (13, 25, 31) .
Current laboratory techniques for the identification of mycobacteria to the species level involve growth in broth, nucleic acid probing, or subculture on solid medium for phenotypic tests, which can take weeks, leading to significant delays in diagnoses. Thus, there is a need for quick and accurate identification of all mycobacteria directly from culture broth. The use of DNA probes (AccuProbe; GenProbe, San Diego, CA) that are specific for the Mycobacterium tuberculosis complex, the M. avium-M. intracellulare complex, M. kansasii, and M. gordonae directly from Bactec TB broth culture has dramatically reduced the time to identification and differentiation of mycobacterial infections (1, 6, 23) . This approach, however, can identify only a limited number of mycobacterium species and requires multiple reactions. If the probe results are negative, a battery of biochemical tests must be performed with or without extracted mycolic acid analysis for definitive species identification.
Several molecular methods including PCR followed by restriction fragment length polymorphism, melt curve analysis, regular sequencing, and pyrosequencing were previously reported to directly identify and differentiate mycobacterial isolates from acid-fast bacillus (AFB)-producing culture broth (15, 16, 26, 32) . In this study, we report the use of a Mycobacterium genus-specific broad-range primer to amplify the partial 16S-23S rRNA gene internal transcribed spacer (ITS) region (24) . After amplification, we then designed 25 mycobacterial species-specific capture oligonucleotide probes to identify and differentiate 17 commonly encountered mycobacterial species in the clinical setting by use of an xMAP suspension array system (Luminex, Austin, TX) (9) . Results were validated in comparison to a reference standard using a combination of biochemical and molecular methods.
(This study was presented in part at the 109th Clinical specimens and recombinant plasmids. AFB-positive culture broth specimens from the Bactec MGIT 960 system were collected consecutively from 30 May 2007 through 9 October 2008 at the Vanderbilt University Medical Center and the Veterans Affairs Tennessee Valley Health Care System. Multiple specimens may be included from the same patient during the study period. Both AFB-positive broth culture specimens and the corresponding mycobacterial isolates were stored at Ϫ80°C for further study. The amplification fragments specific for M. gordonae, M. intracellulare, M. kansasii, and M. tuberculosis, which were generated by PCR (see below), were cloned into the pCR2.1 vector (Invitrogen, Carlsbad, CA). The DNA concentration of recombinant plasmid standards (pCR-Mg, pCR-Mi, pCR-Mk, and pCR-Mt) was calibrated by spectrophotometry at 260 nm (17) . Each inserted plasmid was adjusted to 10,000 copies/l and stored at Ϫ80°C.
Specimen processing, mycobacterial culture, and identification. The specimens were processed within 24 h of collection. Standard sample decontamination with N-acetyl-L-cysteine (0.5% final concentration)-NaOH (2% final concentration) and concentration by centrifugation were performed for sputum and other nonsterile specimens as described previously (21) . The volume of the final sediment was approximately 2 ml. Part of the sediment was used for the AFB smear, which was then stained using auramine-rhodamine fluorochrome staining (21) . Part of the N-acetyl-L-cysteine-NaOH sediment or sterile specimen was inoculated onto Löwenstein-Jensen solid medium and into 7H12 broth liquid medium that was monitored for growth using the Bactec 960 instrument. Bactec MGIT 960 broth medium that yielded a positive culture signal was considered positive for mycobacteria after confirmation by AFB staining. The clinical mycobacterial isolates were identified to the species level by standard biochemical and DNA probe procedures (3, 33) , and their identities were confirmed by high-performance liquid chromatography (HPLC) analysis by Tennessee State Laboratory Services as previously described (4) .
Nucleic acid extraction. Total nucleic acids were extracted from the AFBpositive MGIT broth medium specimens by using a NucliSens easyMAG system (bioMerieux, Inc., Durham, NC). Briefly, 200 l of contents was mixed with 900 l of lysis buffer (bioMerieux, Inc.) under a biosafety hood within a biosafety level 3 laboratory. After thorough vortexing, the mixture was transferred out and placed into the instrument by using a default extraction protocol (20, 30) . Total nucleic acids were eluted in 55 l of elution buffer (bioMerieux, Inc.). For each reference mycobacterial or nonmycobacterial strain, one loop of purified colony was added into 1 ml of sterile water. The mixture was vortexed, heated at 94°C for 10 min, and briefly centrifuged. The supernatant was considered to be extract and stored at 4°C (11) . The volume used for nucleic acid amplification was 5 l for both clinical specimen and strain extracts.
PCR amplification. A broad-range primer set (Sp1 [5Ј-ACC TCC TTT CTA AGG AGC ACC-3Ј] and Sp2 [5Ј-biotin-GAT GCT CGC AAC CAC TAT YCA-3Ј, where Y is C or T]) was designed to amplify a 221-bp portion of the M. tuberculosis 16S-23S ITS modified from that reported previously (24, 34) . In brief, 50 l of a PCR mixture contained the following: 1ϫ buffer, 1.5 mM MgCl 2 , 10% glycerol, 200 M deoxynucleoside triphosphates, 1 M each primer, 0.025 units/l AmpliTaq Gold DNA polymerase (Applied Biosystems), and 5 l of DNA extract. PCR amplification was performed by use of an ABI 9700 thermal cycler (Applied Biosystems, Foster City, CA) with 40 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 45 s.
Capture probe design and microsphere coupling. One mycobacterium genusspecific (MYC) and 35 species-specific probes were synthesized with a C12 amino modifier modification at the 5Ј end (Integrated DNA Technologies, Inc., Coralville, IA). Probes were designed to be 20 nucleotides in length and complementary in sequence to the biotinylated strand of the amplification products (Table 1) . Probes were coupled to carboxylated microspheres by using a previously described carbodiimide coupling method (8, 9) . Briefly, for each coupling, 5 ϫ 10 6 carboxylated microspheres were resuspended in 100 mM 2-(N-morpholino)ethanesulfonic acid (MES) (pH 4.5) and mixed with 1 nM of amine-substi- 
a Each probe was labeled with C12 amino modifier at the 5Ј end.
VOL. 47, 2009 DIFFERENTIATION OF CLINICALLY RELEVANT MYCOBACTERIA 3815 tuted probe oligonucleotide, followed by the addition of 25 g of N-(3-dimethylaminopropyl)-NЈ-ethylcarbodiimide (EDC) and incubation in the dark for 30 min. The addition of EDC and incubation were repeated, and the microspheres were washed. Coupled microspheres were stored in TE (pH 8.0) (10 mM TrisHCl, 1 mM EDTA) at 2°C to 8°C in the dark. Coupling efficacy was determined by hybridization to synthetic oligonucleotide targets (9) . Amplification product identification. The amplified products were further characterized by an xMAP suspension array on a Luminex (Austin, TX) 200 instrument. In brief, after PCR amplification, 2 l of each reaction mixture was added to hybridization solution (3 M tetramethylammonium chloride, 50 mM Tris-HCl [pH 8.0], 4 mM EDTA [pH 8.0], 0.1% Sarkosyl) containing a mixture of 5,000 of each probe-coupled microsphere set in a 50-l total reaction mixture volume. Reaction mixtures were denatured at 95°C for 5 min and hybridized at 45°C for 15 min. Hybridized amplicons were labeled by the addition of 25 l of hybridization solution containing 250 ng of streptavidin-R-phycoerythrin (Molecular Probes) and incubation at 45°C for 5 min (9) . A red laser identified each bead (or target) by its color coding, while a green laser detected the hybridization signal associated with each bead. Results for each channel are expressed as the median fluorescence intensity values (9) . The cutoff value for each target was determined as the mean plus 3 times the standard deviation of the negative controls for each target (12, 18) . terrae; and (xvii) M. xenopi. Specimens were considered unusual mycobacterium species if they were reactive to genus-specific probes but not to any speciesspecific probes.
Housekeeping gene detection. The human ␤-actin gene was amplified as an internal amplification control. The primers and fluorophore hydrolysis probes for the human ␤-actin gene and real-time PCR protocol were reported previously (17) .
Statistical analysis. Statistical comparisons were performed with Epi Info software (version 6; CDC, Atlanta, GA). The accuracy of the MycoID system for the identification of mycobacteria to the species level was determined in comparison to a reference in a combination of biochemical testing, DNA probe hybridization, and fatty acid HPLC analysis. Sensitivity and specificity were determined. Odd ratios, 95% confidence limits, and P values were calculated; P values of Յ0.05 were considered statistically significant.
RESULTS
The MycoID system contained three components: (i) specimen processing and nucleic acid extraction, (ii) amplification of the Mycobacterium genus-specific ITS region by using PCR with a broad-range primer set, and (iii) detection and determination of 17 clinically encountered Mycobacterium species by using an xMAP suspension array with 26 species-specific probes ( Table 1) . We first used lysis buffer to disinfect specimens, lyse human and bacterial cells, and stabilize released nucleic acids and then adapted the magnetic bead-based easyMAG system for nucleic acid extraction. All DNAs extracted from MGIT broth specimens tested positive for the human ␤-actin gene by real-time TaqMan PCR, indicating that they were free of amplification inhibitors.
The analytical sensitivity of the MycoID system was determined by using recombinant plasmids pCR-Mg, pCR-Mi, pCR-Mk, and pCR-Mt, to which the amplification product from M. gordonae, M. intracellulare, M. kansasii, or M. tuberculosis was inserted. Serial 10-fold dilutions of the four plasmids ranging from 1 to 10,000 copies/reaction were tested by the MycoID system. The four plasmids were tested either separately (single existence) or together in a 1:1:1:1 ratio (mixed existence), and each plasmid and dilution were run in triplicate. All four plasmids were hybridized by the genus-specific MYC probe, and each plasmid was hybridized by the corresponding species-specific probes. The analytical sensitivities for M. gordonae, M. intracellulare, M. kansasii, and M. tuberculosis were 10, 1, 1, and 10 copies/reaction, respectively, determined to be either a single or mixed existence (Table 2) , which are equivalent to 500, 50, 50, and 500 copies/ml, respectively, when applied to MGIT broth culture specimens.
The analytical specificity of the MycoID system was tested by use of a panel of mycobacterial and nonmycobacterial strains. The genus-specific MYC probe detected all mycobacterial strains, and species-specific probes detected the corresponding mycobacterial species correctly. No cross-reactions among complexes, groups, and species were revealed. The MycoID system did not react with any nonmycobacterium strains including S. aureus, S. pneumoniae, K. pneumoniae, A. baumannii, P. aeruginosa, L. pneumophila, M. pneumoniae, N. asteroides, N. brasiliensis, R. equi, C. albicans, C. neoformans, and A. fumigatus.
During the 16-month study period, a total of 271 consecutive AFB-positive Bactec 960 broth medium specimens were collected from 181 patients. Specimen types included 208 (76.8%) sputum samples, 18 (66.4%) surgical tissue/wound samples, 15 (5.5%) bronchial washing specimens, 14 (5.2%) bronchial alveolar lavage samples, 10 (3.7%) stool samples, 5 (1.8%) other sterile fluid samples, and 1 (0.4%) gastric aspirate sample. By use of an identification standard using a combination of bio- Table 3 ). The overall agreements between the MycoID system and the standard for mycobacterial species identification were 87.7% and 97.8% when a perfect match and one match in codetection were used, respectively ( Table 3) . The diagnostic performance of the MycoID system for mycobacterium detection and identification of isolates to the species level was determined by using the 271 AFB-positive MGIT broth culture specimens. In all, the MycoID system possessed sensitivity and specificity of 97.1% and 98.8%, respectively, when a standard including a combination of biochemical, probe hybridization, and cell wall fatty acid profiles was used ( Table 4 ). The MycoID system presented perfect performance for the detection and identification of M. tuberculosis complex isolates. Fifteen specimens, which were all from sputum samples, falsely tested positive for M. gordonae by the MycoID system, resulting in a relatively low specificity of 94.2% for the identification of this species (Table 4) .
Among 157 specimens identified as belonging to the M. avium-M. intracellulare complex by both methods, 27 (17.2%) and 130 (82.8%) were recovered from sterile (surgical tissue/ wound, bronchial washing fluid, bronchoalveolar lavage fluid, and other sterile fluid samples) and nonsterile (sputum, stool, and gastric aspirate samples) sites, respectively. The MycoID system was able to detect and identify 98 (62.4%) M. avium, 57 (36.3%) M intracellulare, and 2 (1.3%) mixed M. avium-M intracellulare specimens. M. avium was recovered more frequently from sterile sites (23.5%) than was M. intracellulare TABLE 3 . Agreement between the MycoID system and standard reference for identification and identification to the species level of 271 mycobacterial isolates directly from AFB-positive MGIT broth culture media a
MycoID system identification
No. of isolates determined by reference identification 
DISCUSSION
In this study, we developed a MycoID system, which combines (i) nucleic acid extraction by the bioMerieux NucliSens easyMAG system (20, 30) , (ii) broad-range PCR amplification of the partial mycobacterial genus-specific 16S-23S ITS region (24) , and (iii) determination of mycobacterial isolates to the species level by the Luminex xMAP suspension array system (9) for the high-throughput detection and identification of Mycobacterium species directly from AFB-positive MGIT culture broth. The overall identification agreement between the standard and the MycoID system was 99.3%. The MycoID system was able to further identify and differentiate M. avium and M. intracellulare within the M. avium-M. intracellulare complex group. The entire MycoID procedure, including specimen processing, can be completed within 5 h, providing another means for a rapid and reliable identification and differentiation of mycobacterium species that is amenable to automation.
The Luminex analyzer interrogates analytes via a flow cell illuminated with focused laser excitation light. High-speed digital signal processing and advanced computer algorithms provide analysis of the xMAP microspheres as they pass through the analyzer. Sample data are processed via statistical techniques to determine the existence of a given target analyte with high sensitivity. The analyzer then takes every valid data point and determines the median of the reporter fluorophore signals to give a median florescence intensity value for that set (9) . We have used this platform extensively in the diagnostic microbiology field including for the detection, typing, and semiqualification of 25 human papillomaviruses (12); detection and differentiation of a panel of respiratory viral and bacterial pathogens (7, 18) ; identification, antibiotic resistance determination, and toxin gene detection of Staphylococcus aureus (28) ; quantitative, multiplexed detection of Salmonella and other diarrheal pathogens (8) ; and screening and differentiation of methicillin-resistant S. aureus and vancomycin-resistant enterococcus isolates (22) .
In addition to rapid mycobacterial pathogen detection and differentiation directly from the AFB-positive broth medium specimens described in this study, the xMAP suspension array system has been used for other tuberculosis research and diagnosis. We have adapted this system following target enrichment multiplex PCR amplification for the detection and differentiation of 24 antituberculosis drug resistance-related mutations (11) . Others previously reported using this system to study the pattern and diversity of cytokine production between tuberculosis infection and disease (27) , perform M. tuberculosis spoligotyping on a rapid and high-throughput scale (5), and detect M. tuberculosis-specific antibodies for tuberculosis diagnosis (14) . As the detection system for several nucleic acid amplification products, this system will provide another rapid and high-throughput system for amplification product identification, differentiation, and characterization.
M. avium and M. intracellulare are closely related organisms and comprise the M. avium-M. intracellulare complex. These organisms share many common characteristics, including the ability to cause life-threatening respiratory infections in people with AIDS. However, pathogenic differences between M. avium and M. intracellulare have been reported. The ability to invade the mucosa of the gastrointestinal tract and cause disseminated disease in AIDS patients has been epidemiologically linked uniquely to M. avium (2, 35) . M. avium could invade intestinal epithelial cells more efficiently than M. intracellulare (19) . M. intracellulare also appears to have a distinct environmental niche, as it has been found to be more prevalent in biofilms and at significantly higher numbers than M. avium (10) . The MycoID system described in this study is able to differentiate between M. avium and M. intracellulare and found that M. avium was recovered more frequently from sterile sites than M. intracellulare, which may provide a tool to better understand the role of M. avium-M. intracellulare complex isolates in human disease.
By the incorporation of broad-range PCR amplification, analytical sensitivities of the MycoID system reached 10 copies/ reaction for four clinical commonly encountered mycobacterial species, including M. intracellulare, M. gordonae, M. kansasii, and M. tuberculosis. In addition to AFB-positive MGIT broth medium specimens, other crude clinical specimens may be used directly by this system for the detection and identification of mycobacterial pathogens. We have successfully detected and identified M. avium, M. intracellulare, and M. marinum-M. ulcerans group isolates from formalin-fixed, paraffin-embedded lung tissue specimens collected from patients with respiratory failure (J. A. Johnson, unpublished data). Larger studies are being planned to explore this assay for the detection and identification to the species level of mycobacterial pathogens directly from a variety of clinical specimens. Overall, the MycoID system presented satisfactory sensitivity and specificity for the rapid detection and identification of mycobacterial species directly from AFB-positive MGIT broth culture media. Perfect performance was noticed when the system was used to detect and identify M. tuberculosis complex isolates. However, it is acknowledged that several mycobacterial species with potential medical relevance, including M. pinnipedii, M. bovis subsp. caprae, and "M. canettii" in the M. tuberculosis complex as well as M. bolletii in the M. chelonae-M. abscessus group, were not included in the study. In addition, we did observe that for 16 sputum specimens, M. gordonae was detected together with other mycobacterium species by the MycoID system, which was significantly higher than the 2 samples detected by the standard method. An extended study is being planned to determine the clinical relevance of these codetections and decide whether a separate, higher cutoff value is needed for M. gordonae.
